Home » Topics » BioWorld Science

BioWorld Science
RSS

DuPont Merck research into protease inhibitors

April 5, 1996

New data, new approvals for DaunoXome

April 5, 1996

Virend entering phase III

April 5, 1996

New protease inhibitors from BMS

April 5, 1996

Nabi foresees phase I/II trials on CMV NeutraGAM

April 5, 1996

Lidakol formulations receive patent protection

April 5, 1996

Pfizer, Microcide to codevelop antibacterial drugs

April 5, 1996

BILD-1351 for HSV infection

April 5, 1996

BMS discloses novel cephalosporins

April 5, 1996

MBI-10 antibiotics effective against resistant staphylococci

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...